Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2

Ginsenoside Rh2 increases the efficacy of doxorubicin (DOX) treatment in murine models of solid and ascites Ehrlich’s adenocarcinoma. In a solid tumor model (treatment commencing 7 days after inoculation), DOX + Rh2 co-treatment was significantly more efficacious than DOX alone. If treatment was sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Popov, Alexander, Klimovich, Anna, Styshova, Olga, Tsybulsky, Alexander, Hushpulian, Dmitry, Osipyants, Andrey, Khristichenko, Anna, Kazakov, Sergey, Ahuja, Manuj, Kaidery, Navneet, Thomas, Bobby, Tishkov, Vladimir, Brown, Abraham, Gazaryan, Irina, Poloznikov, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838402/
https://www.ncbi.nlm.nih.gov/pubmed/35163891
http://dx.doi.org/10.3390/molecules27030628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838402/
https://www.ncbi.nlm.nih.gov/pubmed/35163891
http://dx.doi.org/10.3390/molecules27030628

Ejemplares similares